FAS seeks help of pharmaceuticals
FAS invites market participants to take an active part in considering and refining (if necessary) a draft List of the Ministry of Health Care for reference medicines includes in vital and essential drugs (VED)
The explanatory note to the draft specifies that the list of reference medicines can be approved on Q III 2017. The List is necessary to register drug prices.
FAS has asked market participants to help promptly refine the list and send their comments and proposals to the Ministry of Health Care (copying to FAS Department for Social Sphere and Trade).